Rafał Suwiński

3.2k total citations
106 papers, 1.5k citations indexed

About

Rafał Suwiński is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rafał Suwiński has authored 106 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Rafał Suwiński's work include Advanced Radiotherapy Techniques (21 papers), Head and Neck Cancer Studies (20 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Rafał Suwiński is often cited by papers focused on Advanced Radiotherapy Techniques (21 papers), Head and Neck Cancer Studies (20 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Rafał Suwiński collaborates with scholars based in Poland, United States and Hungary. Rafał Suwiński's co-authors include B. Maciejewski, H. Rodney Withers, R. Tarnawski, Krzysztof Składowski, Jerzy Wydmański, Jeremy M. G. Taylor, Tomasz Rutkowski, Leszek Miszczyk, A. Wygoda and A. Zajusz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rafał Suwiński

97 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafał Suwiński Poland 20 638 627 456 440 250 106 1.5k
A. Hartley United Kingdom 20 847 1.3× 537 0.9× 880 1.9× 746 1.7× 91 0.4× 69 1.9k
Jean‐Marc Bachaud France 20 363 0.6× 837 1.3× 577 1.3× 251 0.6× 162 0.6× 49 1.7k
Rafael Martínez‐Monge Spain 27 926 1.5× 984 1.6× 919 2.0× 281 0.6× 187 0.7× 128 2.3k
James Jer‐Min Jian Taiwan 23 778 1.2× 475 0.8× 842 1.8× 406 0.9× 173 0.7× 32 1.9k
Gabrielle Brown United States 10 382 0.6× 801 1.3× 224 0.5× 293 0.7× 302 1.2× 15 1.4k
Mary Ellyn Witt United States 17 607 1.0× 552 0.9× 710 1.6× 997 2.3× 237 0.9× 24 1.5k
Lisbeth Juhler Andersen Denmark 26 963 1.5× 751 1.2× 1.3k 2.8× 1.2k 2.8× 214 0.9× 51 2.3k
Roger K.C. Ngan China 18 945 1.5× 491 0.8× 826 1.8× 1.1k 2.5× 235 0.9× 43 2.1k
Aleksandar Dagović Serbia 19 557 0.9× 753 1.2× 355 0.8× 468 1.1× 128 0.5× 42 1.4k
Hanne Primdahl Denmark 23 775 1.2× 520 0.8× 839 1.8× 826 1.9× 360 1.4× 63 2.0k

Countries citing papers authored by Rafał Suwiński

Since Specialization
Citations

This map shows the geographic impact of Rafał Suwiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafał Suwiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafał Suwiński more than expected).

Fields of papers citing papers by Rafał Suwiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafał Suwiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafał Suwiński. The network helps show where Rafał Suwiński may publish in the future.

Co-authorship network of co-authors of Rafał Suwiński

This figure shows the co-authorship network connecting the top 25 collaborators of Rafał Suwiński. A scholar is included among the top collaborators of Rafał Suwiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafał Suwiński. Rafał Suwiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cybulska-Stopa, Bożena, Anna M. Czarnecka, Marcin Ziętek, et al.. (2023). 1115P Comparison of efficacy and toxicity of dabrafenib/trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice. Annals of Oncology. 34. S672–S672. 2 indexed citations
2.
Cybulska-Stopa, Bożena, Marcin Ziętek, Łukasz Galus, et al.. (2023). Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma. Targeted Oncology. 18(2). 235–245. 2 indexed citations
4.
Czarnecka, Anna M., Bożena Cybulska-Stopa, Marcin Ziętek, et al.. (2022). Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers. 14(9). 2123–2123. 5 indexed citations
5.
Czarnecka, Anna M., Bożena Cybulska-Stopa, Marcin Ziętek, et al.. (2022). Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence. Journal of Clinical Medicine. 11(8). 2239–2239. 4 indexed citations
6.
Cybulska-Stopa, Bożena, Marcin Ziętek, Anna M. Czarnecka, et al.. (2021). Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. Journal of Dermatological Treatment. 33(4). 2168–2174. 8 indexed citations
7.
Suwiński, Rafał. (2021). Prophylactic cranial irradiation in SCLC. Translational Lung Cancer Research. 10(4). 2071–2078. 6 indexed citations
8.
Woźniak, Grzegorz, Maciej Misiołek, Wiesław Bal, et al.. (2020). Randomised clinical trial on 7-days-a-week postoperative radiotherapy vs. concurrent postoperative radio-chemotherapy in locally advanced cancer of the oral cavity/oropharynx. British Journal of Radiology. 93(1116). 20200288–20200288. 2 indexed citations
9.
Cybulska-Stopa, Bożena, Renata Pacholczak‐Madej, Grażyna Kamińska‐Winciorek, et al.. (2020). First-Line Treatment of Advanced/Metastatic Melanoma with Anti-PD-1 Antibodies: Multicenter Experience in Poland. Immunotherapy. 13(4). 297–307. 10 indexed citations
10.
Małusecka, Ewa, Ewa Chmielik, Rafał Suwiński, et al.. (2020). Significance of HPV16 Viral Load Testing in Anal Cancer. Pathology & Oncology Research. 26(4). 2191–2199. 7 indexed citations
11.
Suwiński, Rafał, et al.. (2020). Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet. PLoS Computational Biology. 16(10). e1008234–e1008234. 14 indexed citations
12.
Składowski, Krzysztof, A. Wygoda, B. Pilecki, et al.. (2012). Radiation-Free Weekend Rescued! Continuous Accelerated Irradiation of 7-Days per Week Is Equal to Accelerated Fractionation With Concomitant Boost of 7 Fractions in 5-Days per Week: Report on Phase 3 Clinical Trial in Head-and-Neck Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 85(3). 741–746. 10 indexed citations
13.
Miszczyk, Leszek, et al.. (2011). Wdrożenie systemu CyberKnife z opcją śledzenia (tracking) w radioterapii stereotaktycznej chorych na raka płuca we wczesnych stopniach klinicznego zaawansowania. Nowotwory Journal of Oncology. 61(6). 581–581.
14.
Blamek, Sławomir, et al.. (2008). Ocena ryzyka przerzutów odległych u chorych na raka krtani napromienianych pooperacyjnie. Otolaryngologia Polska. 62(2). 149–157. 1 indexed citations
15.
Suwiński, Rafał, et al.. (2007). Radioterapia 4-D w praktyce klinicznej: wykorzystanie radiochirurgii stereotaktycznej z bramkowaniem u chorych z nowotworowym guzem płuca. Nowotwory Journal of Oncology. 57(2). 105–105. 1 indexed citations
16.
Składowski, Krzysztof, B. Maciejewski, R. Tarnawski, et al.. (2006). Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial. International Journal of Radiation Oncology*Biology*Physics. 66(3). 706–713. 55 indexed citations
17.
Nowara, Elżbieta & Rafał Suwiński. (2005). [Time factor in radiotherapy and chemotherapy for small cell lung cancer].. PubMed. 73(1). 23–31. 1 indexed citations
18.
Utracka-Hutka, B., et al.. (2003). Clinical course of breast cancer in carriers of BRCA1 germline mutations. Contemporary Oncology/Współczesna Onkologia. 7(10). 742–753. 1 indexed citations
19.
Maciejewski, B., R. Tarnawski, Leszek Miszczyk, A Hliniak, & Rafał Suwiński. (2001). To the ranch and back - benefits vs. costs in altered radiotherapy for head and neck cancers*. Nowotwory Journal of Oncology. 51(1). 11–11. 1 indexed citations
20.
Suwiński, Rafał, Jeremy M. G. Taylor, & H. Rodney Withers. (1999). The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect. Radiotherapy and Oncology. 50(1). 57–66. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026